← Back to Search

Local Anesthetic

Erector Spinae Plane Block for Cesarean Section Complications (ESPCS Trial)

Phase 3
Waitlist Available
Led By Albert Moore, MD
Research Sponsored by McGill University Health Centre/Research Institute of the McGill University Health Centre
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Patients undergoing scheduled Cesarean delivery
Be between 18 and 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up three months
Awards & highlights

ESPCS Trial Summary

This trial is testing whether the Erector Spinae Plane Block is more effective than intrathecal morphine for post-cesarean delivery pain relief.

ESPCS Trial Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

ESPCS Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~three months
This trial's timeline: 3 weeks for screening, Varies for treatment, and three months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
24 hour area under the curve pain scores
Secondary outcome measures
Analgesic usage
Incidente of persistent surgical pain
Measurement of quality of recovery after cesarean delivery
+2 more

ESPCS Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Erector Spinae Plane BlockExperimental Treatment1 Intervention
Group II: Intrathecal morphineActive Control1 Intervention
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Erector Spinae Plane Block
2020
Completed Phase 2
~1060

Find a Location

Who is running the clinical trial?

Thammasat UniversityOTHER
78 Previous Clinical Trials
9,277 Total Patients Enrolled
McGill University Health Centre/Research Institute of the McGill University Health CentreLead Sponsor
446 Previous Clinical Trials
159,566 Total Patients Enrolled
Albert Moore, MDPrincipal InvestigatorMcGill University Health Centre/Research Institute of the McGill University Health Centre
4 Previous Clinical Trials
160 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Does this program allow for people who are twenty or older to enroll?

"Individuals that meet the age criteria of being over 18 and under 45 are being recruited for this trial."

Answered by AI

How many test subjects are being monitored in this experiment?

"The trial is still recruiting patients, as of the most recent update on clinicaltrials.gov. The trial was first posted on February 1st, 2020 and was last edited on February 3rd, 2020. They are looking for a total of 160 patients at a single location."

Answered by AI

Are there any restrictions in place for who can take part in this experiment?

"Within the target age bracket of 18 to 45, this clinical trial needs 160 individuals that have undergone a cesarean section. The most important criterion that candidates must meet is as follows: being patients that have undergone scheduled Cesarean delivery."

Answered by AI

Are there any patients you are still looking to enroll in this clinical trial?

"Yes, this clinical trial is recruiting patients as of the most recent update on clinicaltrials.gov (2/3/2020). This study was originally posted on 2/1/2020."

Answered by AI

What is the governing body's stance on Erector Spinae Plane Block?

"Erector Spinae Plane Block is considered safe, as Phase 3 trials have both some efficacy data and multiple rounds of safety data."

Answered by AI

Does a body of research exist for Erector Spinae Plane Block?

"There are currently 62 different clinical trials underway that are researching Erector Spinae Plane Block. 16 of those trials are in Phase 3, which is the final stage of testing before a treatment can be approved. The majority of trials for Erector Spinae Plane Block are based in Boston, Massachusetts, but there are 138 locations running trials for this treatment."

Answered by AI
~31 spots leftby Apr 2025